These kits are manufactured in accordance with the 98/79 EC directive for in vitro diagnostic devices. Only CE marked products can be used for diagnostic applications in Europe.
These kits are intended for in vitro diagnostic use.
These kits are for research use only and are not intended to be used for diagnostic procedures.
Federal Drug Administration, FDA validates diagnostic kits for in vitro diagnostic use in the United States.
Biological risk products.
Storage between 2 and 8 ° C.
Reactive in liquid form.
Reactive in lyophilized form.
Reactive in frozen form.
Stability after opening at 2-8 ° C.
Products that can be refrozen.
Stability 12 months after refreezing at -20 ° C.
Plasma deficient for fibrinogen assay
Immuno-depleted human plasma then buffered with 20mM HEPES
10 x 1.0 mL
The Safety Data Sheets and Notices are accessible to our registered customers.
Fibrinogen is a soluble protein made by the liver. Under the action of thrombin, fibrinogen is converted into fibrin.
In association with FXIII, calcium ions, fibrin forms a stable network which ensures coagulation.
This plasma is stable if stored frozen at -40 to -80 °C.
The stability of the product is 7 days at -20 ° C.
Ready to use after thawing (4 min at 37 ° C)
Plasmas verified negative for all tests required by the FDA
The frozen, immuno-depleted plasmas are certified to have less than 1% for the deficient factor considered, both for the antigenic assay and for functional hemostasis.